Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Update

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) saw a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 1,039,200 shares, an increase of 121.2% from the February 13th total of 469,800 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 200 shares, the short-interest ratio is currently 5,196.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Recordati Industria Chimica e Farmaceutica stock remained flat at $55.54 during midday trading on Tuesday. The company had a trading volume of 14 shares, compared to its average volume of 9. The business's 50 day moving average price is $55.54 and its two-hundred day moving average price is $53.53. Recordati Industria Chimica e Farmaceutica has a 52 week low of $52.25 and a 52 week high of $52.25. The company has a market cap of $11.46 billion, a PE ratio of 27.77 and a beta of 0.30.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.